Section 109051 - [Effective 1/1/2025] Definitions For purposes of this chapter, the following terms have the following definitions:
(a) "DEHP" means Di(2-ethylhexyl) phthalate.(b) "Intentionally added DEHP" means DEHP that a manufacturer has intentionally added to an intravenous solution container or intravenous tubing product that has a functional or technical effect on the product.(c) "Intravenous solution containers" means a container used to house medicine, fluid, or nutrition therapy that is intravenously administered to patients in a hospital, outpatient, or other health care facility.(d) "Intravenous tubing" means any tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant.(e) "Ortho-phthalates" means a class of chemicals that are esters of ortho-phthalic acid, including all of the following: (1) Benzyl-butyl phthalate (BBP) 85-68-7.(2) Dibutyl phthalate (DBP) 84-74-2.(3) Dicyclohexyl phthalate (DCHP) 84-61-7.(4) Di-(2-ethylhexyl) phthalate (DEHP) 117-81-7.(5) Diethyl phthalate (DEP) 84-66-2.(6) Di-isobutyl phthalate (DIBP) 84-69-5.(7) Di-isodecyl phthalate (DIDP) 26761-40-0.(8) Di-isononyl phthalate (DINP) 28553-12-0.(9) Di-n-hexyl phthalate (DnHP) 84-75-3.(10) Di-n-octyl phthalate (DNOP) 117-84-0.(11) Di-n-pentyl (DnPP) phthalate 131-18-0.(12) Diisoheptyl phthalate (DIHP) 71888-89-6.(f) "Unintentionally added DEHP" means DEHP in an intravenous solution container or intravenous tubing product that is not used for functional or technical effect on the product.Ca. Health and Saf. Code § 109051
Added by Stats 2024 ch 562 (AB 2300),s 1, eff. 1/1/2025.